A Seattle biotechnology company developing programmable RNA medicines that recruit the ADAR enzyme to correct genetic errors, guided by AI.
Shape Therapeutics
Released December 20, 2025
Structure-aware transformer that makes zero-shot, per-adenosine predictions of ADAR-mediated A-to-I RNA editing to guide therapeutic guide-RNA design.